48,466
edits
Difference between revisions of "Tuberous sclerosis"
Jump to navigation
Jump to search
→Genes
(re-order) |
(→Genes) |
||
| Line 39: | Line 39: | ||
*TSC2.<ref>{{OMIM|191092}}</ref> | *TSC2.<ref>{{OMIM|191092}}</ref> | ||
**Some evidence to suggest it is more often implicated in malignant tumours (than TSC1).<ref name=pmid9827727>{{cite journal |author=Al-Saleem T, Wessner LL, Scheithauer BW, ''et al.'' |title=Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex |journal=Cancer |volume=83 |issue=10 |pages=2208–16 |year=1998 |month=November |pmid=9827727 |doi= |url=}}</ref> | **Some evidence to suggest it is more often implicated in malignant tumours (than TSC1).<ref name=pmid9827727>{{cite journal |author=Al-Saleem T, Wessner LL, Scheithauer BW, ''et al.'' |title=Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex |journal=Cancer |volume=83 |issue=10 |pages=2208–16 |year=1998 |month=November |pmid=9827727 |doi= |url=}}</ref> | ||
**TSC2 mutations have a higher prevalence (than TSC1 mutations) and are considered more aggressive.<ref name=pmid17003820>{{cite journal |author=Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA |title=Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors |journal=Kidney Int. |volume=70 |issue=10 |pages=1777–82 |year=2006 |month=November |pmid=17003820 |doi=10.1038/sj.ki.5001853 |url=}}</ref> | |||
==Incidence== | ==Incidence== | ||